Featured News

Global study to test malaria drug to protect health workers from COVID-19

Clare Ridley, MD, an assistant professor of anesthesiology
Clare Ridley, MD, works with colleagues during the pandemic. Worldwide, as many as 10 percent of those infected with the novel coronavirus are frontline health-care workers. Now researchers at Washington University School of Medicine in St. Louis are helming a worldwide study of up to 55,000 health-care workers to establish whether the antimalaria drugs chloroquine and hydroxychloroquine might prevent or reduce the severity of COVID-19 infections in such workers. ERIN JONES/BARNES-JEWISH HOSPITAL
View Content